Market Place
Sourcing Support
BMS Links Up With Faro To Use AI To Improve Trial Protocols
31 Mar 2026 //
FIERCE BIOTECH
BMS, Novartis, Gilead, Iovance Dinged In CBER Untitled Letters
30 Mar 2026 //
FIERCE PHARMA
BMS Camzyos Shows Ph3 Efficacy In Adolescent oHCM Trial
29 Mar 2026 //
BUSINESSWIRE
Takeda Clears Path To FDA With Phase 3 Data On $4B Psoriasis Bet
28 Mar 2026 //
FIERCE BIOTECH
Switch Study Shows Stability With Cobenfy In Patients
28 Mar 2026 //
PHARMIWEB
Insitro & BMS Collaboration Expanded with Nomination of Targets
23 Mar 2026 //
BUSINESSWIRE
Bristol Myers Squibb Strengthens Ohcm Leadership With Camzyos
23 Mar 2026 //
PHARMIWEB
FDA approves Bristol Myers`s cancer drug for Hodgkin`s lymphoma
20 Mar 2026 //
FDA
Bristol Myers Squibb To Report Results For First Quarter 2026
19 Mar 2026 //
BUSSINESSWIRE
BMS Brings Ashley Park Aboard Campaign Honoring Oncologists
18 Mar 2026 //
FIERCE PHARMA
FDA Expands Label For BMS` Sotyktu To Treat Psoriatic Arthritis
10 Mar 2026 //
FIERCE PHARMA
BMS` Celmod Drug Improves Myeloma PFS In Phase 3
09 Mar 2026 //
FIERCE BIOTECH
Bristol Myers Squibb Announces Dividend
02 Mar 2026 //
BUSINESSWIRE
BMS` ADC Hits Primary Endpoints In Phase 3 Breast Cancer Trial
27 Feb 2026 //
FIERCE BIOTECH
Evinova Secures AI Deals with Astellas, AstraZeneca
24 Feb 2026 //
FIERCE BIOTECH
BMS, Catalent Further Whittle Workforces
23 Feb 2026 //
BIOSPACE
BMS Announces Positive Results from Registrational Phase 2 Study
23 Feb 2026 //
PHARMIWEB
Bristol Myers Squibb Joins TD Cowen Health Care Conference
23 Feb 2026 //
BUSINESSWIRE
SC Clears Zydus to Sell Cancer Drug; BMS Told to Map Patents
11 Feb 2026 //
ECONOMICTIMES
AI Transforms Pharma`s Financials Beyond Drug Discovery
11 Feb 2026 //
BIOSPACE
BMS And Evinova Pen Global Development Partnership
09 Feb 2026 //
FIERCE BIOTECH
Evinova, Bristol Myers Squibb Partner To Enhance Clinical
09 Feb 2026 //
BUSINESSWIRE
BMS Beats Again Despite Eliquis And Cobenfy Disappointments
05 Feb 2026 //
BIOSPACE
BMS Turns Focus To New Growth Drivers As Legacy Meds Decline
05 Feb 2026 //
FIERCE PHARMA
OXB Inks Multi-Year Supply Deal With Bristol Myers Squibb
04 Feb 2026 //
GLOBENEWSWIRE
BMS Lauds Breyanzi`s Shutout Against Cancer With Soccer Legend
04 Feb 2026 //
FIERCE PHARMA
BMS, J&J Factor In HCP Education Before Milvexian Data Drop
03 Feb 2026 //
FIERCE PHARMA
Bristol Myers Halts Zydus` Biosimilar Cancer Drug Sales
29 Jan 2026 //
ECONOMICTIMES
BMS Snags Top Neuro Researcher From Eisai—Chutes & Ladders
23 Jan 2026 //
FIERCE BIOTECH
BMS pens $850M tumor pact with T-cell engager biotech Janux
22 Jan 2026 //
FIERCE BIOTECH
NICE Recommends Opdivo for Resectable NSCLC Cancer
21 Jan 2026 //
PHARMIWEB
T1D Fund Appoints Teresa Foy, Ph.D. to Advance Therapies
21 Jan 2026 //
PR NEWSWIRE
Scotland Approves Dual Immunotherapy for MMRd/MSI-H mCRC Cancer
20 Jan 2026 //
PHARMIWEB
Scotland Approves Dual Immunotherapy for MMRd/MSI-H mCRC
20 Jan 2026 //
PHARMIWEB
Microsoft, Bristol Myers Advance AI Lung Cancer Detection
20 Jan 2026 //
BUSINESSWIRE
Syngene Expands Research Collaboration With Bristol Myers Squibb
20 Jan 2026 //
ECONOMICTIMES
PRI Files Amicus Brief in SCOTUS Medical Freedom Case
16 Jan 2026 //
PR NEWSWIRE
BMS Initiates Early-Stage Ventures Amid Pharma`s Late-Stage Rush
12 Jan 2026 //
BIOSPACE
Bristol Myers CEO Pledges To `Cast A Broad Net` In Dealmaking
12 Jan 2026 //
FIERCE BIOTECH
Bristol Myers Squibb Reports Phase 3 SCOUT-HCM Trial Success
12 Jan 2026 //
PHARMIWEB
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Biotech Showcase Facilitates Investor, Pharma, And Media Access
08 Jan 2026 //
PHARMIWEB
Bristol Myers Squibb at J.P. Morgan`s 44th Healthcare Conference
02 Jan 2026 //
BUSINESSWIRE
Bristol Myers Lines Up Many Launches For India With `AI` Speed
24 Dec 2025 //
ECONOMICTIMES
Bristol Myers Squibb Enhances U.S. Access To Vital Medicines
19 Dec 2025 //
BUSINESSWIRE
BMS’ Cobenfy TV Ad Is Latest Target Of FDA Untitled Letter Spree
19 Dec 2025 //
FIERCE PHARMA
Bristol Myers Squibb To Release Q4 2025 Results On Feb 5, 2026
18 Dec 2025 //
BUSINESSWIRE
Bristol Myers Squibb Launches Ai-Powered `Mosaic` Hub In Mumbai
17 Dec 2025 //
INDPHARMAPOST
Harbour BioMed Signs Antibody Deal with Bristol Myers Squibb
16 Dec 2025 //
PR NEWSWIRE
FDA Grants Priority Review for Opdivo Plus Chemo in Lymphoma
11 Dec 2025 //
PHARMIWEB
BMS & BioNtech Unveil Promising Early Results for TNBC therapy
11 Dec 2025 //
INDPHARMAPOST
Bristol Myers Squibb Announces Dividend Increase
10 Dec 2025 //
BUSINESSWIRE
BioNTech, Bristol Myers Squibb Unveil Positive Phase 2 Results
09 Dec 2025 //
GLOBENEWSWIRE
BMS Shares Targeted Lymphoma Therapy Data at ASH
08 Dec 2025 //
BUSINESSWIRE
BMS`s Breyanzi Is First CAR-T Approved in US for Rare Lymphoma
06 Dec 2025 //
BUSINESSWIRE
Terray Reaches AI Drug Discovery Milestone With BMS
03 Dec 2025 //
BUSINESSWIRE
Bristol Myers Squibb Continues ADEPT-2 Phase 3 Study In AD
03 Dec 2025 //
PHARMIWEB
Bristol Myers Squibb Showcases Hematology Pipeline At ASH 2025
01 Dec 2025 //
BUSINESSWIRE
Bristol Myers Must Face $6.7 B Lawsuit Over Delayed Cancer Drug
01 Dec 2025 //
REUTERS
BMS Joins Citi`s 2025 Global Healthcare Conference
26 Nov 2025 //
BUSINESSWIRE
